0027| Volume 128, SUPPLEMENT , 154989, March 2022

Leveraging Automated Machine Learning to provide NAFLD screening diagnosis: Proposed machine learning models

      Background and Objective: Non-alcoholic fatty liver disease (NAFLD) is reported to be the only hepatic ailment increasing in its prevalence concurrently with both; obesity & Type 2 Diabetes Mellitus. Abdominal ultrasonography is done for NAFLD screening diagnosis which has a high monetary cost associated with it. • In the wake of a massive strain on global health resources due to COVID-19 pandemic, NAFLD is bound to be neglected and shelved. Machine learning is explored, here, to propose screening-diagnostic tools for NAFLD that can be easily deployed without the requirement of substantial resources and can provide instantaneous screening-diagnosis predictive results.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect